Business & Regulation

Voting is now open for our 2025 Company of the Year Awards.

Technological advances are opening up new drug development opportunities for rare diseases.

The increasing focus on sustainability in the pharmaceutical industry amongst CDMOs reveals the key strategies and initiatives being undertaken.

How a LEGO biomanufacturing facility brought out the inner child in attendees at an industry trade show.

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

EFPIA signs joint declaration championing open trade in the EU.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

The public’s perception of the industry is low. How can we fix it?

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?